Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C

Trial Profile

Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 05 Feb 2019

At a glance

  • Drugs Eltrombopag (Primary) ; Boceprevir; Interferon; Ribavirin
  • Indications Hepatitis C; Thrombocytopenia
  • Focus Therapeutic Use
  • Acronyms SQUELCH-C
  • Most Recent Events

    • 28 Jan 2019 Status changed from recruiting to discontinued.
    • 09 Apr 2013 New trial record
    • 01 Apr 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top